Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Cited In for PubMed (Select 22322308)

1.

Automated prostate cancer detection via comprehensive multi-parametric magnetic resonance imaging texture feature models.

Khalvati F, Wong A, Haider MA.

BMC Med Imaging. 2015 Aug 5;15(1):27. doi: 10.1186/s12880-015-0069-9.

2.

Computer-aided transrectal ultrasound: does prostate HistoScanning™ improve detection performance of prostate cancer in repeat biopsies?

Hamann MF, Hamann C, Trettel A, Jünemann KP, Naumann CM.

BMC Urol. 2015 Jul 30;15:76. doi: 10.1186/s12894-015-0072-z.

3.

Definitive 3D-CRT for clinically localized prostate cancer: modifications of the clinical target volume following a prostate MRI and the clinical benefits.

Yamaguchi S, Ohguri T, Fujii M, Yahara K, Hayashida Y, Fujimoto N, Korogi Y.

Springerplus. 2015 Jul 15;4:347. doi: 10.1186/s40064-015-1138-9. eCollection 2015.

4.

Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists.

Yoo S, Kim JK, Jeong IG.

Korean J Urol. 2015 Jul;56(7):487-97. doi: 10.4111/kju.2015.56.7.487. Epub 2015 Jun 30. Review.

5.

Multiparametric-MRI in diagnosis of prostate cancer.

Ghai S, Haider MA.

Indian J Urol. 2015 Jul-Sep;31(3):194-201. doi: 10.4103/0970-1591.159606. Review.

6.

Quantitative identification of magnetic resonance imaging features of prostate cancer response following laser ablation and radical prostatectomy.

Litjens GJ, Huisman HJ, Elliott RM, Shih NN, Feldman MD, Viswanath S, Fütterer JJ, Bomers JG, Madabhushi A.

J Med Imaging (Bellingham). 2014 Oct;1(3):035001. doi: 10.1117/1.JMI.1.3.035001. Epub 2014 Oct 27.

PMID:
26158070
7.

Repeat Targeted Prostate Biopsy under Guidance of Multiparametric MRI-Correlated Real-Time Contrast-Enhanced Ultrasound for Patients with Previous Negative Biopsy and Elevated Prostate-Specific Antigen: A Prospective Study.

Jang DR, Jung DC, Oh YT, Noh S, Han K, Kim K, Rha KH, Choi YD, Hong SJ.

PLoS One. 2015 Jun 17;10(6):e0130671. doi: 10.1371/journal.pone.0130671. eCollection 2015.

8.

Evaluation of Multiparametric Magnetic Resonance Imaging in Detection and Prediction of Prostate Cancer.

Wang R, Wang H, Zhao C, Hu J, Jiang Y, Tong Y, Liu T, Huang R, Wang X.

PLoS One. 2015 Jun 12;10(6):e0130207. doi: 10.1371/journal.pone.0130207. eCollection 2015.

9.

Multiparametric MRI guidance in first-time prostate biopsies: what is the real benefit?

Acar Ö, Esen T, Çolakoğlu B, Vural M, Onay A, Sağlıcan Y, Türkbey B, Rozanes İ.

Diagn Interv Radiol. 2015 Jul-Aug;21(4):271-6. doi: 10.5152/dir.2015.46014.

10.

False positive and false negative diagnoses of prostate cancer at multi-parametric prostate MRI in active surveillance.

Quon JS, Moosavi B, Khanna M, Flood TA, Lim CS, Schieda N.

Insights Imaging. 2015 Aug;6(4):449-63. doi: 10.1007/s13244-015-0411-3. Epub 2015 May 23.

11.

Current role of multiparametric magnetic resonance imaging in the management of prostate cancer.

Katelaris NC, Bolton DM, Weerakoon M, Toner L, Katelaris PM, Lawrentschuk N.

Korean J Urol. 2015 May;56(5):337-45. doi: 10.4111/kju.2015.56.5.337. Epub 2015 Apr 6. Review.

12.

PROMIS--Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer.

El-Shater Bosaily A, Parker C, Brown LC, Gabe R, Hindley RG, Kaplan R, Emberton M, Ahmed HU; PROMIS Group.

Contemp Clin Trials. 2015 May;42:26-40. doi: 10.1016/j.cct.2015.02.008. Epub 2015 Mar 3.

13.

Multiparametric magnetic resonance imaging of prostate: the evolution of a technique.

Muglia VF.

Radiol Bras. 2014 Sep-Oct;47(5):V-VI. doi: 10.1590/0100-3984.2014.47.5e1. No abstract available.

14.

Multiparametric magnetic resonance imaging of the prostate: current concepts.

Bittencourt LK, Hausmann D, Sabaneeff N, Gasparetto EL, Barentsz JO.

Radiol Bras. 2014 Sep-Oct;47(5):292-300. doi: 10.1590/0100-3984.2013.1863. Review.

15.

MRI-targeted biopsies versus systematic transrectal ultrasound guided biopsies for the diagnosis of localized prostate cancer in biopsy naïve men.

Peltier A, Aoun F, Lemort M, Kwizera F, Paesmans M, Van Velthoven R.

Biomed Res Int. 2015;2015:571708. doi: 10.1155/2015/571708. Epub 2015 Jan 27.

16.

Prostate cancer discrimination in the peripheral zone with a reduced field-of-view T(2)-mapping MRI sequence.

Yamauchi FI, Penzkofer T, Fedorov A, Fennessy FM, Chu R, Maier SE, Tempany CM, Mulkern RV, Panych LP.

Magn Reson Imaging. 2015 Jun;33(5):525-30. doi: 10.1016/j.mri.2015.02.006. Epub 2015 Feb 14.

PMID:
25687187
17.

The role of pathology correlation approach in prostate cancer index lesion detection and quantitative analysis with multiparametric MRI.

Fedorov A, Penzkofer T, Hirsch MS, Flood TA, Vangel MG, Masry P, Tempany CM, Mulkern RV, Fennessy FM.

Acad Radiol. 2015 May;22(5):548-55. doi: 10.1016/j.acra.2014.12.022. Epub 2015 Feb 13.

18.

Feasibility of multiparametric prostate magnetic resonance imaging in the detection of cancer distribution: histopathological correlation with prostatectomy specimens.

Kitamura K, Muto S, Yokota I, Hoshimoto K, Kaminaga T, Noguchi T, Sugiura S, Ide H, Yamaguchi R, Furui S, Horie S.

Prostate Int. 2014 Dec;2(4):188-95. doi: 10.12954/PI.14067. Epub 2014 Dec 30.

19.

The role of 3-tesla diffusion-weighted magnetic resonance imaging in selecting prostate cancer patients for active surveillance.

Jeong CW, Park YH, Hwang SI, Lee S, Jeong SJ, Hong SK, Byun SS, Lee HJ, Lee SE.

Prostate Int. 2014 Dec;2(4):169-75. doi: 10.12954/PI.14057. Epub 2014 Dec 30.

20.

The future perspectives in transrectal prostate ultrasound guided biopsy.

Hwang SI, Lee HJ.

Prostate Int. 2014 Dec;2(4):153-60. doi: 10.12954/PI.14062. Epub 2014 Oct 1. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk